GAITHERSBURG, Md., Dec. 19, 2019 /PRNewswire/ — MaxCyte, the global clinical-stage cell-based therapies and life sciences company, announced today that Shruti Abbato has joined the Company as Executive Vice President, Business Development for CARMA Cellular Therapies. Ms. Abbato will lead development of new partnerships for the Company’s CARMA platform programmes.
{iframe}https://www.prnewswire.com/news-releases/maxcyte-appoints-new-executive-vice-president-business-development-for-carma-cellular-therapies-and-provides-clinical-trial-update-300977414.html?tc=eml_cleartime{/iframe}